T2 Biosystems, Inc. (TTOO)
OTCMKTS · Delayed Price · Currency is USD
0.0110
-0.0295 (-59.00%)
Oct 20, 2025, 3:10 PM EDT
T2 Biosystems Market Cap
T2 Biosystems has a market cap or net worth of $308.5 thousand as of October 20, 2025. Its market cap has decreased by -99.12% in one year.
Market Cap
308.50K
Enterprise Value
17.17M
Revenue
7.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since August 7, 2014, T2 Biosystems's market cap has decreased from 274.87M to 308.50K, a decrease of -99.89%. That is a compound annual growth rate of -45.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 308.50K | -96.51% |
| Dec 31, 2024 | 8.84M | -65.23% |
| Dec 29, 2023 | 25.42M | 144.54% |
| Dec 30, 2022 | 10.39M | -87.87% |
| Dec 31, 2021 | 85.67M | -53.30% |
| Dec 31, 2020 | 183.46M | 235.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |